What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Rheumatologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
D Scott Cunningham MD, PhD
Site Editor, MDLinx
MMP-3 and COMP predict PsA response to TNF inhibitors
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Lung Involvement in Connective Tissue Diseases: A Comprehensive Review and A Focus On Rheumatoid Arthritis Autoimmunity Reviews, May 17, 2013 Clinical Article
2 Does rheumatoid arthritis have an effect on audiovestibular tests European Archives of Oto-Rhino-Laryngology, May 17, 2013 Clinical Article
3 Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany Full Text Open Access Rheumatology: Research and Reviews, May 17, 2013 Clinical Article
4 Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study Extension The Journal of Rheumatology, May 16, 2013 Clinical Article
5 Cholesteryl Ester Transfer Protein in Patients with Rheumatoid Arthritis The Journal of Rheumatology, May 16, 2013 Clinical Article
6 Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis Rheumatology International, May 16, 2013 Clinical Article
7 Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors Clinical Rheumatology, May 16, 2013 Clinical Article
8 Angiogenesis in rheumatoid arthritis is directly fostered by TLR5 ligation and indirectly through IL-17 induction Arthritis & Rheumatism, May 16, 2013 Review Article
9 Association between tumor necrosis factor-α (TNF-α) promoter -308 G/A and response to TNF-α blockers in rheumatoid arthritis: a meta-analysis Modern Rheumatology, May 15, 2013 Evidence Based Medicine Review Article Clinical Article
10 The role of vitamin D supplementation in patients with rheumatic diseases Nature Reviews Rheumatology , May 15, 2013 Clinical Guideline Clinical Article
11
JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical
Modern Rheumatology, May 14, 2013
Clinical Article
Exclusive Author Commentary
12 Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study Clinical Rheumatology, May 14, 2013 Clinical Article
13 Enrichment of vitamin D response elements in RA-associated loci supports a role for vitamin D in the pathogenesis of RA Genes and Immunity, May 14, 2013 Clinical Article
14 Synovial cyst of the hip in a patient with rheumatoid arthritis Modern Rheumatology, May 14, 2013
15 Severe Guillain-Barre syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review Clinical Rheumatology, May 14, 2013 Review Article
16 RAHelp: An online intervention for individuals with rheumatoid arthritis Arthritis Care & Research , May 13, 2013 Clinical Article
17 Impact of Fatigue on Psychological Outcomes in Adults Living With Rheumatoid Arthritis Nursing Research, May 13, 2013 Clinical Article
18 The risk of venous thromboembolism in patients with rheumatoid arthritis Arthritis Care & Research , May 13, 2013 Clinical Article
19 Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis Investigative Ophthalmology & Visual Science, May 13, 2013 Clinical Article
20 Impact of Fatigue on Psychological Outcomes in Adults Living With Rheumatoid Arthritis Nursing Research, May 10, 2013 Clinical Article
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryIn a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryIn a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summaryIndexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close